-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Opiant Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2021.
- Opiant Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$278K, a 48.8% increase year-over-year.
- Opiant Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$1.51M, a 14% increase year-over-year.
- Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.12M, a 4505% decline from 2020.
- Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$46.1K, a 109% decline from 2019.
- Opiant Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2019 was $504K, a 987% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)